Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

BONE Insider Trading

Xtant Medical Holdings, Inc. | Surgical & Medical Instruments & Apparatus

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Xtant Medical Holdings, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2011-08-17 21:33 2011-08-16 WICKWIRE JON M. Director BUY $2.05 19,500 $39,975 225,031 +9.5%
2011-08-17 04:10 2011-08-16 COOK GUY S Director, Officer, 10% owner - CEO BUY $3.20 14,833 $47,466 12,817,004 +0.1%
2011-08-16 21:32 2011-08-16 Godfrey Mitchell T Director SELL $1.95 28,000 $54,701 751,467 -3.6%
2011-07-12 19:10 2011-07-11 COOK GUY S Director, Officer, 10% owner - CEO SELL $2.63 150,000 $394,500 12,802,171 -1.2%
2011-06-07 01:56 2011-06-06 COOK GUY S Director, Officer, 10% owner - CEO SELL $2.97 150,000 $445,815 12,952,171 -1.1%
2011-05-05 02:23 2011-05-02 GANDOLFO JOHN P Officer - CFO BUY $3.52 9,943 $34,999 9,943 +100.0%
2011-05-03 20:10 2011-05-02 COOK GUY S Director, Officer, 10% owner - CEO BUY $3.52 142,045 $499,998 13,102,171 +1.1%
2011-05-03 20:10 2011-05-02 COOK GUY S Director, Officer, 10% owner - CEO SELL $3.20 150,000 $480,435 12,960,126 -1.1%
2011-04-21 19:01 2011-04-19 LOPACH MICHAEL A Director BUY $2.95 50,847 $149,999 33,898 +100.0%
2011-04-21 19:08 2011-04-19 Swanson Kent L Director BUY $2.95 50,000 $147,500 221,223 +29.2%
SHOW ENTRIES

How to Interpret $BONE Trades

Not every insider transaction in Xtant Medical Holdings, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $BONE shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for BONE

Insider activity data for Xtant Medical Holdings, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $BONE, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.